| Title |
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
|
|---|---|
| Published in |
Diabetologia, August 2018
|
| DOI | 10.1007/s00125-018-4678-z |
| Pubmed ID | |
| Authors |
Christoph Wanner, Nikolaus Marx |
X Demographics
The data shown below were collected from the profiles of 47 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 8 | 17% |
| Spain | 7 | 15% |
| Australia | 2 | 4% |
| Denmark | 2 | 4% |
| Canada | 2 | 4% |
| United States | 2 | 4% |
| Oman | 1 | 2% |
| China | 1 | 2% |
| Ecuador | 1 | 2% |
| Other | 5 | 11% |
| Unknown | 16 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 57% |
| Practitioners (doctors, other healthcare professionals) | 10 | 21% |
| Scientists | 8 | 17% |
| Science communicators (journalists, bloggers, editors) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 146 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 18 | 12% |
| Other | 17 | 12% |
| Researcher | 15 | 10% |
| Student > Master | 15 | 10% |
| Student > Ph. D. Student | 10 | 7% |
| Other | 28 | 19% |
| Unknown | 43 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 44% |
| Biochemistry, Genetics and Molecular Biology | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Agricultural and Biological Sciences | 4 | 3% |
| Computer Science | 3 | 2% |
| Other | 8 | 5% |
| Unknown | 48 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2020.
All research outputs
#1,232,599
of 26,017,215 outputs
Outputs from Diabetologia
#665
of 5,646 outputs
Outputs of similar age
#25,532
of 346,197 outputs
Outputs of similar age from Diabetologia
#20
of 69 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,646 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,197 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.